POSTER: ABCL-517 Phase III Trial of Subcutaneous Epcoritamab + R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2
L. Sehn, M. Chamuleau, G. Lenz, M. Clausen, C. Haioun, K. Izutsu, A. Davies, Jun Zhu, T. Oki, E. Szafer-Glusman, R. Conlon, Hueiyu Chiou, D. Ipe, B. Elliott, Jun Wu, G. Salles
{"title":"POSTER: ABCL-517 Phase III Trial of Subcutaneous Epcoritamab + R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2","authors":"L. Sehn, M. Chamuleau, G. Lenz, M. Clausen, C. Haioun, K. Izutsu, A. Davies, Jun Zhu, T. Oki, E. Szafer-Glusman, R. Conlon, Hueiyu Chiou, D. Ipe, B. Elliott, Jun Wu, G. Salles","doi":"10.1016/s2152-2650(23)00730-9","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10370,"journal":{"name":"Clinical Lymphoma Myeloma and Leukemia","volume":"41 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lymphoma Myeloma and Leukemia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/s2152-2650(23)00730-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
